Colgate-Palmolive Company $CL Shares Sold by Glenmede Trust Co. NA

Key Points

• Glenmede Trust reduced its Colgate-Palmolive stake by 7.3% in the first quarter, selling 46,946 shares and retaining 595,265 shares worth approximately $50.7 million. Institutional investors collectively own 80.41% of the company.
• Colgate-Palmolive’s second-quarter adjusted EPS rose to $0.99, beating estimates, while revenue increased 4.9% to $5.36 billion. Gross margins expanded by 140 basis points to 61.5%, supported by productivity gains and organic sales growth.
• Management reaffirmed its full-year sales outlook, but muted North American demand, slower organic growth and potential tariff costs pose risks. The company also maintains a quarterly dividend of $0.53 per share, equivalent to a 2.3% yield.

Glenmede Trust Co. NA reduced its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 7.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 595,265 shares of the company's stock after selling 46,946 shares during the quarter. Glenmede Trust Co. NA owned about 0.07% of Colgate-Palmolive worth $50,734,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Kemnay Advisory Services Inc. purchased a new position in Colgate-Palmolive in the 4th quarter valued at about $25,000. CBIZ Investment Advisory Services LLC grew its holdings in shares of Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock worth $26,000 after buying an additional 150 shares in the last quarter. TD Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 61.4% during the fourth quarter. TD Capital Management LLC now owns 326 shares of the company's stock worth $26,000 after buying an additional 124 shares in the last quarter. Triumph Capital Management raised its position in shares of Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company's stock valued at $26,000 after buying an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $26,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Second-quarter adjusted/base-business EPS was $0.99, exceeding the $0.95 consensus estimate and rising from $0.92 a year earlier. Revenue increased 4.9% year over year to $5.36 billion, in line with expectations. Colgate-Palmolive Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability improved, with GAAP and base-business gross margins expanding 140 basis points to 61.5%. Productivity gains and organic sales growth helped offset increased brand investment, while Latin America led regional growth and toothpaste maintained its global leadership. Colgate Q2 Earnings Beat Estimates on Strong Margins
• Neutral Sentiment: Management reaffirmed its full-year sales forecast, with expected revenue of approximately $20.8 billion to $21.6 billion. Maintaining guidance supports stability, but the range signals limited visibility in a choppy consumer environment. Colgate-Palmolive Reaffirms Annual Sales Forecast
• Negative Sentiment: North American demand remained muted, creating concern that the company’s strongest international performance may not fully offset weakness in its largest developed market. Investors also focused on management’s warning that new tariffs could outweigh a recent refund benefit, potentially pressuring future earnings. Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall
• Negative Sentiment: GAAP EPS declined 5% to $0.86 despite the adjusted earnings beat, and organic sales growth was only 2.4%. The combination of slower underlying growth, domestic weakness and tariff risk is outweighing the quarter’s positive margin and earnings performance.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $91.29 on Friday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The firm has a 50 day moving average price of $90.97 and a 200 day moving average price of $89.44. The company has a market cap of $73.05 billion, a price-to-earnings ratio of 35.52, a PEG ratio of 4.82 and a beta of 0.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. The firm had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. Colgate-Palmolive's revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.92 earnings per share. Sell-side analysts predict that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive's dividend payout ratio is presently 82.49%.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $99.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Wells Fargo & Company increased their price target on Colgate-Palmolive from $92.00 to $95.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 8th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $96.00 to $104.00 and gave the stock an "overweight" rating in a report on Thursday, July 16th. Piper Sandler lifted their price objective on Colgate-Palmolive from $92.00 to $96.00 and gave the company an "overweight" rating in a research report on Thursday, July 9th. Finally, Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the company a "buy" rating in a research note on Tuesday, April 21st. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $97.82.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.